Showing results (121-130 of 196) with videos related to
Sort By:
Pageof 20
Neurobiology of Aging|January 31, 2006
Determinants of platelet activation in Alzheimer's diseaseGiovanni Ciabattoni, Ettore Porreca, Concetta Di Febbo, et al.Blood|November 6, 2009
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapyAlfredo Dragani, Silvia Pascale, Antonio Recchiuti, et al.Diabetes|October 17, 2015
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 DiabetesFrancesco Zaccardi, Alessandro Rizzi, Giovanna Petrucci, et al.Kidney International|July 16, 2017
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies ConferenceColin Baigent, William G Herrington, Josef Coresh, et al.Journal of the American Society of Nephrology : JASN|May 4, 2017
Biliary Tract and Liver Complications in Polycystic Kidney DiseaseParminder K Judge, Charlie H S Harper, Benjamin C Storey, et al.Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney DiseaseWilliam Herrington, Natalie Staplin, Parminder K Judge, et al.Hypertension (Dallas, Tex. : 1979)|September 9, 2022
Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic EpidemiologyNatalie Staplin, William G Herrington, Federico Murgia, et al.The Lancet. Diabetes & Endocrinology|March 24, 2018
Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort studyWilliam G Herrington, Jesus Alegre-Díaz, Rachel Wade, et al.Clinical Pharmacology and Therapeutics|September 6, 2006
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart diseaseGiulia Renda, Stefania Tacconelli, Marta L Capone, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2016
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)Natalie Staplin, Richard Haynes, William G Herrington, et al.Pageof 20